MYLAN 351 (Haloperidol 0.5 mg)
Pill imprint MYLAN 351 has been identified as Haloperidol 0.5 mg.
Haloperidol is used in the treatment of dementia; psychosis; icu agitation; nausea/vomiting; mania (and more), and belongs to the drug class miscellaneous antipsychotic agents. Risk cannot be ruled out during pregnancy. Haloperidol 0.5 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for MYLAN 351
- 0.5 mg
- 6.00 mm
- Prescription only
- Drug Class:
- Miscellaneous antipsychotic agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- silicon dioxide
FD&C Yellow No. 6
sodium lauryl sulfate
|NDC Code||Manufacturer / Repackager|
|51079-0733||UDL Laboratories Inc|
|18837-0348||Innoviant Pharmacy Inc (repackager)|
|68071-0494||Nucare Pharmaceuticals Inc (repackager)|
Note: Inactive ingredients may vary.
More about haloperidol
- Haloperidol decanoate
- Haloperidol solution
- Haloperidol tablets
- Haloperidol (Advanced Reading)
- Haloperidol Intramuscular (Advanced Reading)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.